Well Pharmaceutical
Well Pharmaceutical is a supplier of pharmaceutical excipients and high-end lubricant base oils and special surfactants.
Launch date
Market cap
CAD497m
Enterprise valuation
CAD563m (Public information from Sep 2024)
Share price
CNY19.5 603351.SS
Nanjing Jiangsu (HQ)
Financials
Estimates*
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 881m | 736m | 1.0b | 1.1b | 1.2b |
| % growth | - | (16 %) | 42 % | 7 % | 4 % |
| EBITDA | 194m | 156m | 171m | 194m | 211m |
| % EBITDA margin | 22 % | 21 % | 16 % | 17 % | 18 % |
| Profit | 128m | 100m | 101m | 95.0m | 112m |
| % profit margin | 15 % | 14 % | 10 % | 9 % | 10 % |
| EV / revenue | 3.3x | 3.8x | 5.0x | 2.9x | 3.4x |
| EV / EBITDA | 14.8x | 18.1x | 30.6x | 16.8x | 18.5x |
| R&D budget | 32.9m | 36.6m | 41.5m | 53.9m | 55.6m |
| R&D % of revenue | 4 % | 5 % | 4 % | 5 % | 5 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about Well Pharmaceutical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
